Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment

Medicine and Dentistry

• Cohort Effect 100%
• Pathophysiology 100%
• Nephropathy 100%
• Metabolic Acidosis 100%
• Functional Status 50%
• Physical Activity 50%
• Functional Limitation 50%
• Supplementation 50%
• Individualization 50%
• Cardiovascular Risk 50%
• Cardiovascular Effect 50%
• Sodium Bicarbonate 50%
• Selective Serotonin Reuptake Inhibitor 50%
• Hematinic 50%
• Lactic Acidosis 50%
• Anaerobic Metabolism 50%
• Hyperphosphatemia 50%
• Protein Energy Wasting 50%
• Sarcopenia 50%
• Quality of Life 50%
• Targeted Therapy 50%
• Skeletal Muscle 50%
• Antidepressant 50%